Sealonix closes on $20M in funding for orthopedic sealant :

Sealonix closes on $20M in funding for orthopedic sealant

Sealonix, a biomaterials company, has closed on $20 million in series A funding to develop their next generation of hemostatic sealants for surgical use. The

Related Keywords

, Sealonix , Biomaterials , Sealant , Hemostatic , Ealant Patch , Bdominopelvic , Rthopedic , Excelestar Ventures , Clinical Trials ,

© 2025 Vimarsana